Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Axillary Nodal Burden in HER2+ and TNBC
- Status
- COMPLETED
- Phase
- N/A
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Status
- RECRUITING
- Phase
- N/A
Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
Advanced Ultrasound Signal Processing of Suspicious Breast Images
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- Status
- RECRUITING
- Phase
- NA
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
CARE (Chemotherapy Alopecia REduction)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
- Status
- RECRUITING
- Phase
- NA
Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.
- Status
- COMPLETED
- Phase
- NA
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AI-Assisted Chemotherapy Side Effect Management
- Status
- RECRUITING
- Phase
- NA
A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2